Atypical haemolytic uraemic syndrome: a case of rare genetic mutation

BMJ Case Rep. 2021 Jul 30;14(7):e244190. doi: 10.1136/bcr-2021-244190.

Abstract

Complement-mediated kidney disease has been an evolving area in the field of nephrology. Atypical haemolytic uraemic syndrome (aHUS) is a rare thrombotic microangiopathy that affects multiple organs, particularly kidneys. The disease is characterised by a triad of haemolytic anaemia, thrombocytopenia and acute kidney injury (AKI). aHUS is most commonly caused by dysregulation of alternative complement pathway. In contrast to shiga toxin-associated haemolytic uraemic syndrome, diarrheal prodrome is usually absent in children with aHUS. We report a 2-year, 9-month-old boy who presented with acute dysentery and AKI. He had an unusual prolonged course of illness with hypocomplementaemia; hence, genetic testing was performed. He had a storming course in the hospital and succumbed to complications of the disease. Genetic study revealed digenic mutation in Complement Factor I and C3 Therefore, it is important to differentiate aHUS from other thrombotic microangiopathies to improve the outcome.

Keywords: genetics; haematology (incl blood transfusion); immunology; paediatrics; renal medicine.

Publication types

  • Case Reports

MeSH terms

  • Atypical Hemolytic Uremic Syndrome* / diagnosis
  • Atypical Hemolytic Uremic Syndrome* / genetics
  • Child
  • Complement Pathway, Alternative
  • Humans
  • Infant
  • Kidney
  • Male
  • Mutation
  • Thrombotic Microangiopathies*